In the latter study, which employed IHC for B-cell subtyping, increased CD8+ T-cell infiltrate/tumour CD138+ B-cell (i.e., PC) infiltrate ratio was also independently associated with improved cancer-specific survival (p < 0.001), whilst there was no significant association between CD20+ B-lymphocytic infiltrate and cancer survival [39]. Here, CD8A is linked to cancer.